Patricia Carr - 26 Feb 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Signature
By: /s/Paz Dizon, as attorney in fact For: Patricia Carr
Issuer symbol
JAZZ
Transactions as of
26 Feb 2026
Net transactions value
-$456,466
Form type
4
Filing time
02 Mar 2026, 17:14:13 UTC
Previous filing
21 Jan 2026
Next filing
09 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carr Patricia SVP, Chief Accounting Officer 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Paz Dizon, as attorney in fact For: Patricia Carr 02 Mar 2026 0001784606

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +2,223 +24% $0.000000 11,605 26 Feb 2026 Direct F1
transaction JAZZ Ordinary Shares Sale $243,222 -1,253 -11% $194.11 10,352 26 Feb 2026 Direct F2, F3
transaction JAZZ Ordinary Shares Sale $213,243 -1,117 -11% $190.91 9,235 27 Feb 2026 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
F2 Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F3 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $193.7300 to $194.4100. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.